
The resubmission follows an FDA Complete Response Letter and cites human factors data showing pouch-opening time fell from 17 to 3 seconds.
What lonvo-z is, how it works, and what a Priority Review designation means for the HAE gene-editing therapy.
On September 8, 2026, the






